GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » ACI Formulations Ltd (DHA:ACIFORMULA) » Definitions » Total Assets

ACI Formulations (DHA:ACIFORMULA) Total Assets : BDT7,332 Mil (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is ACI Formulations Total Assets?

ACI Formulations's Total Assets for the quarter that ended in Mar. 2024 was BDT7,332 Mil.

During the past 12 months, ACI Formulations's average Total Assets Growth Rate was -8.60% per year. During the past 3 years, the average Total Assets Growth Rate was 7.10% per year. During the past 5 years, the average Total Assets Growth Rate was 3.00% per year. During the past 10 years, the average Total Assets Growth Rate was 9.40% per year.

During the past 13 years, ACI Formulations's highest 3-Year average Total Assets Growth Rate was 23.20%. The lowest was -0.80%. And the median was 7.10%.

Total Assets is connected with ROA %. ACI Formulations's annualized ROA % for the quarter that ended in Mar. 2024 was 5.33%. Total Assets is also linked to Revenue through Asset Turnover. ACI Formulations's Asset Turnover for the quarter that ended in Mar. 2024 was 0.17.


ACI Formulations Total Assets Historical Data

The historical data trend for ACI Formulations's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACI Formulations Total Assets Chart

ACI Formulations Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,023.22 5,514.85 5,659.96 6,469.38 6,674.32

ACI Formulations Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,237.09 6,674.32 6,769.81 7,136.23 7,331.99

ACI Formulations Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

ACI Formulations's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets=Total Equity (A: Jun. 2023 )+Total Liabilities (A: Jun. 2023 )
=3052.673+3621.647
=6,674

ACI Formulations's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=3236.247+4095.742
=7,332

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ACI Formulations  (DHA:ACIFORMULA) Total Assets Explanation

Total Assets is connected with ROA %.

ACI Formulations's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=385.552/( (7136.231+7331.989)/ 2 )
=385.552/7234.11
=5.33 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

ACI Formulations's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1233.543/( (7136.231+7331.989)/ 2 )
=1233.543/7234.11
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

ACI Formulations Total Assets Related Terms

Thank you for viewing the detailed overview of ACI Formulations's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


ACI Formulations (DHA:ACIFORMULA) Business Description

Traded in Other Exchanges
N/A
Address
ACI Centre, 245, Tejgaon Industrial Area, Dhaka, BGD, 1208
ACI Formulations Ltd is an agricultural chemicals manufacturer. The principal activities of the company are manufacturing and marketing a number of agrochemical and consumer products. The company has structured its operations into the following business segments - Crop Care and Public Health segment, which manufactures and sell crop care and public health products; Mosquito Coil segment is engaged in the manufacturing and selling of mosquito coil products; the Aerosol segment is engaged in the manufacturing and selling aerosol and air freshener products; and Paint segment which manufactures and sells paint products. It derives key revenue from the Crop Care and Public Health segment.

ACI Formulations (DHA:ACIFORMULA) Headlines

No Headlines